{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:15:14Z","timestamp":1790133314751,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd004959.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T00:00:00Z","timestamp":1377561600000}}],"reference-count":103,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004959.pub4","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T18:22:15Z","timestamp":1377627735000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Opioids compared to placebo or other treatments for chronic low-back pain"],"prefix":"10.1002","volume":"2014","author":[{"given":"Luis Enrique","family":"Chaparro","sequence":"first","affiliation":[{"name":"Hospital Pablo Tobon Uribe; Anesthesiology Department; Medellin Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea D","family":"Furlan","sequence":"additional","affiliation":[{"name":"Institute for Work & Health; 481 University Avenue, Suite 800 Toronto ON Canada M5G 2E9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Deshpande","sequence":"additional","affiliation":[{"name":"University Health Network; TWH-Comprehensive Pain Unit; 399 Bathurst St 4th Floor Toronto ON Canada M5T 2S8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mailis-Gagnon","sequence":"additional","affiliation":[{"name":"Toronto Western Hospital Comprehensive Pain Program; Department of Medicine; 399 Bathurst Street Fell Pavillion 4F811 Toronto Ontario Canada M5T 2S8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Atlas","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital; Medical Practices Evaluation Center; 50 Staniford Street 9th Floor Boston MA USA 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis C","family":"Turk","sequence":"additional","affiliation":[{"name":"University of Washington; Department of Anesthesiology and Pain Medicine; Box 356540 Seattle Washington USA 98195"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8,27]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD004959.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1517\/14656566.2010.497720","article-title":"Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study","volume":"11","author":"Buynak","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"8","key":"10.1002\/14651858.CD004959.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.pain.2012.02.028","article-title":"Analgesic tolerance without demonstrable opioid-induced hyperalgesia: A double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain","volume":"153","author":"Chu","year":"2012","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD004959.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.clinthera.2010.04.018","article-title":"Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase","volume":"32","author":"Gordon","year":"2010","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD004959.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpain.2006.09.011","article-title":"Efficacy and safety of OPANA ER (Oxymorphone Extended Release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: A 12-week, randomized, double-blind, placebo-controlled study","volume":"8","author":"Hale","year":"2007","journal-title":"Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD004959.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1185\/03007995.2010.484723","article-title":"Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain","volume":"26","author":"Hale","year":"2010","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1002\/14651858.CD004959.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1185\/030079906X162692","article-title":"A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain","volume":"23","author":"Katz","year":"2007","journal-title":"Current Medical Research and Opinion"},{"issue":"1-2","key":"10.1002\/14651858.CD004959.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD004959.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1177\/147323000903700615","article-title":"The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, double-blind, 6-week studies","volume":"37","author":"O'Donnell","year":"2009","journal-title":"Journal of International Medical Research"},{"issue":"12","key":"10.1002\/14651858.CD004959.pub4-BIB0009|cit9","first-page":"2454","article-title":"Analgesic efficacy and safety of tramadol\/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial","volume":"31","author":"Peloso","year":"2004","journal-title":"Journal of Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD004959.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0149-2918(03)80071-1","article-title":"Tramadol\/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study","volume":"25","author":"Ruoff","year":"2003","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD004959.pub4-BIB0011|cit11","first-page":"772","article-title":"Efficacy of tramadol in treatment of chronic low back pain","volume":"27","author":"Schnitzer","year":"2000","journal-title":"Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD004959.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jpainsymman.2011.04.006","article-title":"Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naive patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study","volume":"42","author":"Steiner","year":"2011","journal-title":"Journal of Pain and Symptom Management"},{"issue":"10","key":"10.1002\/14651858.CD004959.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1185\/03007995.2012.726216","article-title":"Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study","volume":"28","author":"Uberall","year":"2012","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"10.1002\/14651858.CD004959.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5055\/jom.2008.0013","article-title":"Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain","volume":"4","author":"Vorsanger","year":"2008","journal-title":"Journal of Opioid Management"},{"issue":"12","key":"10.1002\/14651858.CD004959.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jpain.2006.05.005","article-title":"Oxytrex minimizes physical dependence while providing effective analgesia: A randomized controlled trial in low back pain","volume":"7","author":"Webster","year":"2006","journal-title":"Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD004959.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1533-2500.2006.00094.x","article-title":"A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions-the ACCPT study","volume":"6","author":"Adams","year":"2006","journal-title":"Pain Practice"},{"issue":"22","key":"10.1002\/14651858.CD004959.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1097\/01.brs.0000186860.23078.a8","article-title":"Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain","volume":"30","author":"Allan","year":"2005","journal-title":"Spine"},{"issue":"1","key":"10.1002\/14651858.CD004959.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clinthera.2007.01.001","article-title":"A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain","volume":"29","author":"Beaulieu","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD004959.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1155\/2013\/164609","article-title":"Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: A placebo-controlled, randomized study","volume":"18","author":"Cloutier","year":"2013","journal-title":"Pain Research and Management"},{"issue":"1","key":"10.1002\/14651858.CD004959.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00482-005-0396-9","article-title":"Oral controlled-release oxycodone for the treatment of chronic pain. Data from 4196 patients","volume":"20","author":"Gaertner","year":"2006","journal-title":"Schmerz"},{"issue":"3","key":"10.1002\/14651858.CD004959.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1155\/2010\/216725","article-title":"Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain","volume":"15","author":"Gordon","year":"2010","journal-title":"Pain Research and Management"},{"key":"10.1002\/14651858.CD004959.pub4-BIB0022|cit22","first-page":"137","article-title":"A comparison of the efficacy and adverse effects of controlled release dihydrocodeine and immediate release dihydrocodeine in the treatment of pain in osteoarthritis and chronic back pain","volume":"1","author":"Gostick","year":"1989","journal-title":"Edinburgh Symposium on Pain Control and Medical Education"},{"issue":"2","key":"10.1002\/14651858.CD004959.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/AJP.0b013e3181817ac8","article-title":"The pain quality response profile of oxymorphone extended release in the treatment of low back pain","volume":"25","author":"Gould","year":"2009","journal-title":"Clinical Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD004959.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1155\/1997\/546061","article-title":"Efficacy of 12 hourly controlled-release codeine compared with as required dosing of acetaminophen plus codeine in patients with chronic low back pain","volume":"2","author":"Hale","year":"1997","journal-title":"Pain Research and Management"},{"issue":"3","key":"10.1002\/14651858.CD004959.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00002508-199909000-00004","article-title":"Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain","volume":"15","author":"Hale","year":"1999","journal-title":"Clinical Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD004959.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpain.2004.09.005","article-title":"Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study","volume":"6","author":"Hale","year":"2005","journal-title":"Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD004959.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1185\/03007990902816970","article-title":"Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study","volume":"25","author":"Hale","year":"2009","journal-title":"Current Medical Research and Opinion"},{"issue":"23","key":"10.1002\/14651858.CD004959.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1097\/00007632-199812010-00014","article-title":"Opioid therapy for chronic noncancer back pain. A randomized prospective study","volume":"23","author":"Jamison","year":"1998","journal-title":"Spine"},{"key":"10.1002\/14651858.CD004959.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1741-7015-5-39","article-title":"Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine","volume":"5","author":"Kalso","year":"2007","journal-title":"BMC Medicine"},{"issue":"25","key":"10.1002\/14651858.CD004959.pub4-BIB0030|cit30","first-page":"1171","article-title":"Analgesic effect and clinical tolerability of the combination of paracetamol 500 mg and caffeine 50 mg versus paracetamol 400 mg and dextropropoxyphene 30 mg in back pain","volume":"25","author":"Kuntz","year":"1996","journal-title":"Presse Medicale"},{"issue":"10","key":"10.1002\/14651858.CD004959.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.clinthera.2007.10.010","article-title":"Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study","volume":"29","author":"Landau","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD004959.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1185\/03007990802579769","article-title":"Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial*","volume":"24","author":"Li","year":"2008","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD004959.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.clinthera.2007.08.001","article-title":"Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison","volume":"29","author":"Likar","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"8995","key":"10.1002\/14651858.CD004959.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(96)90339-6","article-title":"Randomised trial of oral morphine for chronic non-cancer pain","volume":"347","author":"Moulin","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004959.pub4-BIB0035|cit35","first-page":"675","article-title":"Comaprison of the efficacy and tolerability of a paracetamol\/codeine fixed dose combination with tramadol in patients with refractory chronic back pain","volume":"48","author":"Muller","year":"1998","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"10.1002\/14651858.CD004959.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1185\/030079906X89784","article-title":"Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules","volume":"22","author":"Nicholson","year":"2006","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD004959.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1185\/030079906X115603","article-title":"Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain","volume":"22","author":"Nicholson","year":"2006","journal-title":"Current Medical Research and Opinion"},{"issue":"10","key":"10.1002\/14651858.CD004959.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1185\/030079907X233179","article-title":"Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain","volume":"23","author":"Pascual","year":"2007","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"10.1002\/14651858.CD004959.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clinthera.2009.02.019","article-title":"Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use","volume":"31","author":"Peniston","year":"2009","journal-title":"Clinical Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD004959.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.clinthera.2006.10.001","article-title":"Efficacy and tolerability of paracetamol\/tramadol (325 mg\/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study","volume":"28","author":"Perrot","year":"2006","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD004959.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1185\/030079906X162818","article-title":"Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study","volume":"23","author":"Portenoy","year":"2007","journal-title":"Current Medical Research and Opinion"},{"issue":"6","key":"10.1002\/14651858.CD004959.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"325-3, 331-3","DOI":"10.5055\/jom.2006.0048","article-title":"A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial","volume":"2","author":"Rauck","year":"2006","journal-title":"Journal of Opioid Management"},{"issue":"1","key":"10.1002\/14651858.CD004959.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5055\/jom.2007.0037","article-title":"A randomized, open-label, multicenter trial comparing once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: improved physical functioning in the ACTION trial","volume":"3","author":"Rauck","year":"2007","journal-title":"Journal of Opioid Management"},{"issue":"4","key":"10.1002\/14651858.CD004959.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0885-3924(99)00079-2","article-title":"Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?","volume":"18","author":"Salzman","year":"1999","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD004959.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5055\/jom.2008.0032","article-title":"Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain","volume":"4","author":"Sarbu","year":"2008","journal-title":"Journal of Opioid Management"},{"issue":"3","key":"10.1002\/14651858.CD004959.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1526-4637.2007.00298.x","article-title":"Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ)","volume":"8","author":"Taylor","year":"2007","journal-title":"Pain Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004959.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pain.2008.12.017","article-title":"Opioid therapy for nonspecific low back pain and the outcome of chronic work loss","volume":"142","author":"Volinn","year":"2009","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD004959.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jpain.2008.06.014","article-title":"Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain","volume":"9","author":"Vondrackova","year":"2008","journal-title":"Journal of Pain"},{"issue":"10","key":"10.1002\/14651858.CD004959.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/j.1742-1241.2007.01500.x","article-title":"Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study","volume":"61","author":"Wallace","year":"2007","journal-title":"International Journal of Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD004959.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clinthera.2006.01.010","article-title":"Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain","volume":"28","author":"Weinstein","year":"2006","journal-title":"Clinical Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD004959.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00007632-198007000-00006","article-title":"Acute low-back pain. An objective analysis of conservative therapy","volume":"5","author":"Wiesel","year":"1980","journal-title":"Spine"},{"key":"10.1002\/14651858.CD004959.pub4-BIB0052|cit52","unstructured":"A randomized double-blind, placebo-controlled Trial to evaluate the efficacy, tolerability and safety of hydrocodone bitartrate controlled-release capsules in opioid-experienced subjects with moderate to severe CLBP. Ongoing study"},{"key":"10.1002\/14651858.CD004959.pub4-BIB0053|cit53","unstructured":"A Randomized, double-blind, placebo-controlled, multicentre trial with an enriched study design to assess the efficacy and safety of oxycodone\/naloxone controlled-release tablets (OXN) compared to placebo in opioid-experienced subjects with moderate to severe pain due to chronic low back pain who require around-the-clock opioid therapy Ongoing study May 2011."},{"key":"10.1002\/14651858.CD004959.pub4-BIB0054|cit54","unstructured":"True functional restoration and analgesia in non-radicular low back pain: a prospective double blind, placebo-controlled study of hydromorphone ER. Ongoing study October 2011."},{"key":"10.1002\/14651858.CD004959.pub4-BIB0055|cit55","unstructured":"A multicentre, 12 week, double-blind, placebo-controlled, randomized withdrawal study to determine the efficacy and safety of ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules in subjects with moderate to severe CLBP. Ongoing study June 2012."},{"key":"10.1002\/14651858.CD004959.pub4-BIB0056|cit56","unstructured":"A 12 week, randomized, double-blind, placebo-controlled, randomized-withdrawal study to evaluate the efficacy and safety of hydrocodone bitartrate extended-release tablets (CEP-33237) at 30 to 90 mg every 12 hours for relief of CLBP who require opioid treatment for an extended period of time. Ongoing study March 2013."},{"issue":"12","key":"10.1002\/14651858.CD004959.pub4-BIB0057|cit57","first-page":"829","article-title":"Risk of recurrence of occupational back pain over three year follow up","volume":"45","author":"Abenhaim","year":"1988","journal-title":"British Journal of Industrial Medicine"},{"issue":"9178","key":"10.1002\/14651858.CD004959.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(99)01312-4","article-title":"Epidemiological factors of chronic low-back pain","volume":"354","author":"Andersson","year":"1999","journal-title":"Lancet"},{"issue":"20","key":"10.1002\/14651858.CD004959.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"13","key":"10.1002\/14651858.CD004959.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"Journal of the American Medical Association"},{"issue":"12","key":"10.1002\/14651858.CD004959.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jclinepi.2005.05.004","article-title":"A checklist to evaluate a report of a non pharmacological trial (CLEAR NPT) was developed using consensus","volume":"58","author":"Boutron","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD004959.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1526-5900(03)00638-2","article-title":"Patient characteristics associated with opioid v. non-steroidal anti-inflammatory drug management of chronic lower back pain","volume":"4","author":"Breckenridge","year":"2003","journal-title":"Journal of Pain"},{"issue":"17","key":"10.1002\/14651858.CD004959.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00007632-199809010-00012","article-title":"The Saskatchewan Health and Back Pain Survey: The prevalence of low back pain and related disability in Saskatchewan adults","volume":"23","author":"Cassidy","year":"1998","journal-title":"Spine"},{"issue":"9377","key":"10.1002\/14651858.CD004959.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0140-6736(03)13819-6","article-title":"Opioids in Italy: is marketing more powerful than the law?","volume":"362","author":"Chinellato","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD004959.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-147-7-200710020-00008","article-title":"Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society\/American College of Physicians clinical practice guideline","volume":"147","author":"Chou","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004959.pub4-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004959.pub3","article-title":"Opioids for chronic low-back pain","author":"Deshpande","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"23","key":"10.1002\/14651858.CD004959.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1097\/01.brs.0000244618.06877.cd","article-title":"Back pain prevalence and visit rates: Estimates from US national surveys, 2002","volume":"31","author":"Deyo","year":"2006","journal-title":"Spine"},{"issue":"8","key":"10.1002\/14651858.CD004959.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1526-4637.2006.00200.x","article-title":"Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?","volume":"8","author":"Edlund","year":"2007","journal-title":"Pain Medicine"},{"issue":"8","key":"10.1002\/14651858.CD004959.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1532-5415.2009.02376.x","article-title":"Pharmacological management of persistent pain in older persons","volume":"57","author":"Ferrell","year":"2009","journal-title":"Journal of the American Geriatrics Society"},{"issue":"5","key":"10.1002\/14651858.CD004959.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00007632-199603010-00017","article-title":"The failed back surgery syndrome-reasons, intraoperative findings and long-term results: a report of 182 operative treatments","volume":"21","author":"Fritsch","year":"1996","journal-title":"Spine"},{"issue":"7","key":"10.1002\/14651858.CD004959.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1097\/00007632-200104010-00018","article-title":"A critical review of reviews on the treatment of chronic low back pain","volume":"26","author":"Furlan","year":"2001","journal-title":"Spine"},{"issue":"18","key":"10.1002\/14651858.CD004959.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/BRS.0b013e3181b1c99f","article-title":"2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group","volume":"34","author":"Furlan","year":"2009","journal-title":"Spine"},{"issue":"9","key":"10.1002\/14651858.CD004959.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1503\/cmaj.100187","article-title":"Opioids for chronic noncancer pain: a new Canadian practice guideline","volume":"182","author":"Furlan","year":"2010","journal-title":"Canadian Medical Association journal"},{"issue":"5","key":"10.1002\/14651858.CD004959.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1155\/2011\/465281","article-title":"A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain","volume":"16","author":"Furlan","year":"2011","journal-title":"Pain Research and Management"},{"issue":"11","key":"10.1002\/14651858.CD004959.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"E668","DOI":"10.1097\/BRS.0b013e318241e5de","article-title":"The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings","volume":"37","author":"Gore","year":"2012","journal-title":"Spine"},{"key":"10.1002\/14651858.CD004959.pub4-BIB0076|cit76","first-page":"1","article-title":"Recovery from low back pain. 1-5 year follow-up of 287 injury-related cases","volume":"254","author":"Greenough","year":"1993","journal-title":"Acta Orthopaedica Scandinavica. Supplementum"},{"issue":"10","key":"10.1002\/14651858.CD004959.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/00043764-199710000-00005","article-title":"Length of disability and cost of workers' compensation low back claims","volume":"39","author":"Hashemi","year":"1997","journal-title":"Occupational and Environmental Medicine"},{"key":"10.1002\/14651858.CD004959.pub4-BIB0078|cit78","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org 2011"},{"issue":"10","key":"10.1002\/14651858.CD004959.pub4-BIB0079|cit79","first-page":"1411","article-title":"A guide to interpreting discordant systematic reviews","volume":"156","author":"Jadad","year":"1997","journal-title":"Canadian Medical Association Journal"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004959.pub4-BIB0080|cit80","first-page":"21","article-title":"Lumbar disc disorders and low-back pain: socioeconomic factors and consequences","volume":"88","author":"Katz","year":"2006","journal-title":"Journal of Bone and Joint Surgery"},{"issue":"1","key":"10.1002\/14651858.CD004959.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00586-010-1541-4","article-title":"A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain","volume":"20","author":"Kuijpers","year":"2011","journal-title":"European Spine Journal"},{"issue":"2","key":"10.1002\/14651858.CD004959.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","article-title":"Systematic review: opioid treatment for chronic back pain: prevalence, efficacy and association with addiction","volume":"146","author":"Martell","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004959.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD004959.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1155\/2003\/184247","article-title":"Attitudes toward opioid use for chronic pain: A Canadian physician survey","volume":"8","author":"Morley-Foster","year":"2003","journal-title":"Pain Research and Management"},{"issue":"12","key":"10.1002\/14651858.CD004959.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7326\/0003-4819-146-12-200706190-00009","article-title":"Ethical issues in stopping randomized trials early because of apparent benefit","volume":"146","author":"Mueller","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004959.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpainsymman.2007.03.015","article-title":"Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety","volume":"35","author":"Noble","year":"2008","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD004959.pub4-BIB0087|cit87","first-page":"1540","article-title":"Failed back surgery syndrome","volume-title":"Bonica's management of pain","author":"Oaklander","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD004959.pub4-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003007","article-title":"Rehabilitation after lumbar disc surgery","author":"Ostelo","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"22","key":"10.1002\/14651858.CD004959.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa064039","article-title":"Surgery versus prolonged conservative treatment for sciatica","volume":"356","author":"Peul","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004959.pub4-BIB0090|cit90","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 5.2 2013"},{"issue":"2","key":"10.1002\/14651858.CD004959.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00007632-198603000-00007","article-title":"The relationship of disability to compensation status in railroad workers","volume":"11","author":"Sanders","year":"1986","journal-title":"Spine"},{"issue":"15","key":"10.1002\/14651858.CD004959.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1097\/00007632-199508000-00004","article-title":"An epidemiological study of episodes of back pain care","volume":"20","author":"Shekelle","year":"1995","journal-title":"Spine"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD004959.pub4-BIB0093|cit93","first-page":"S1","article-title":"Scientific approach to the assessment and management of activity-related spinal disorders: a monograph for physicians","volume":"12","author":"Spitzer","year":"1987","journal-title":"Spine"},{"issue":"7199","key":"10.1002\/14651858.CD004959.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/bmj.318.7199.1662","article-title":"Predicting who develops chronic low back pain in primary care: a prospective study","volume":"318","author":"Thomas","year":"1999","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD004959.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00002508-199712000-00011","article-title":"What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients?","volume":"13","author":"Turk","year":"1997","journal-title":"Clinical Journal of Pain"},{"issue":"9784","key":"10.1002\/14651858.CD004959.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(11)60402-9","article-title":"Treatment of chronic non-cancer pain","volume":"377","author":"Turk","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD004959.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/01.BRS.0000065484.95996.AF","article-title":"Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group","volume":"28","author":"Tulder","year":"2003","journal-title":"Spine"},{"issue":"15","key":"10.1002\/14651858.CD004959.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00007632-199708010-00013","article-title":"The epidemiology of low back pain in the rest of the world. A review of surveys in low- and middle-income countries","volume":"22","author":"Volinn","year":"1997","journal-title":"Spine"},{"issue":"24","key":"10.1002\/14651858.CD004959.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/00007632-199612150-00004","article-title":"The course of back pain in primary care","volume":"21","author":"Korff","year":"1996","journal-title":"Spine"},{"issue":"3","key":"10.1002\/14651858.CD004959.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pain.2004.02.019","article-title":"Potent opioids for chronic musculoskeletal pain: flying blind?","volume":"109","author":"Korff","year":"2004","journal-title":"Pain"},{"issue":"9859","key":"10.1002\/14651858.CD004959.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004959.pub4-BIB0102|cit102","first-page":"324","article-title":"Survey of Ontario primary care physicians' experiences with opioid prescribing","volume":"57","author":"Wenghofer","year":"2011","journal-title":"Canadian Family Physician"},{"issue":"6","key":"10.1002\/14651858.CD004959.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jpain.2013.01.769","article-title":"Clinicians' attitudes and beliefs about opioids survey (CAOS): Instrument development and results of a national physician survey","volume":"14","author":"Wilson","year":"2013","journal-title":"Journal of Pain"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004959.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T15:17:32Z","timestamp":1714317452000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004959.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Back and Neck Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,27]]},"references-count":103,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004959.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,27]]}}}